Sponsor Pipeline

Chendu DIAO Pharmaceutical Group CO., LTD. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
3
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT07629544
A Study of DA-302168S in Participants With Overweight/Obesity		 Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-10 NCT07755150 A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07629544 A Study of DA-302168S in Participants With Overweight/Obesity Overweight and Obesity Recruiting
Phase 2
NCT07755150 A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2… Type 2 Diabetes Mellitus Not Yet Recruiting
Disease Areas
Obesity (1) Type 2 Diabetes (1) Diabetes (1)
Get alerts when Chendu DIAO Pharmaceutical Group CO., LTD.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free